Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

New molecules can prevent cell death in hair follicles.

HDAC inhibitors help brain cells grow and improve brain function.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Some gonadal hormone drugs can block filovirus entry into cells.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Invasomes with 0.5% limonene greatly improve skin delivery of finasteride.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Tadalafil and Finasteride may help treat aggressive melanoma.

Finasteride's molecular properties and active sites were identified using computational methods.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.